Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase NA 2Phase 3 2Phase 2/3 2Phase 2 1Phase 1 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Classical hematology 1

Conditions

Urinary Bladder Neoplasms 1Neoplasms 1Febrile Neutropenia 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 182Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Amoxicillin-Potassium Clavulanate Combination × Clear all
NCT05392634 2022-05-31

MACS

N.N. Petrov National Medical Research Center of Oncology

Phase 3 Unknown
98 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT03003273 2019-02-01

DALFEN

All India Institute of Medical Sciences

Phase 3 Terminated
142 enrolled
Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡